课题基金 / 基金详情

TAXOTERE W/ CONTINUOUS INFUSION TOPOTECAN IN ADVANCED MALIGNANCIES

TAXOTERE W/ CONTINUOUS INFUSION TOPOTECAN IN ADVANCED MALIGNANCIES
泰索帝联合拓扑替康持续输注治疗晚期恶性肿瘤
批准号：
6303005
负责人：
James A Posey
金额：
$2.95万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-12-01 至 2000-11-30
来源：
https://reporter.nih.gov/project-details/6303005
关键词：
antineoplastics clinical research clinical trials combination chemotherapy human subject human therapy evaluation neoplasm /cancer chemotherapy neoplastic growth paclitaxel topotecan

项目摘要

项目成果

James A Posey的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Phase I study of two cytotoxic chemo agents which have broad spectrum of activity and non-cumulative myelosuppression. Toxicities to date have been fever + neutropenia occurring in 3 patients grade 3 neuropenia in ~ 50% of patients receiving at lease 1 cycle grade 2 asthenia in 6 patients. No objective responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UAB 0282 GEMCITABINE
Rebeccamycin in hepatabiliary cancers
TAXOTERE W/ CONTINUOUS INFUSION TOPOTECAN IN ADVANCED MALIGNANCIES
PNU 214936 IN ADVANCED ADENOCARCINOMAS OF THE BREAST
海外基金